September 27-29, 2021 (Boston, MA)
2021 has been an eventful year for us, bringing several exciting partnerships and a host of upgraded decentralized clinical trial capabilities. We are excited to be a presenting sponsor for the 11th annual DPHARM: Disruptive Innovations conference. Join us as we discuss the advantages of running AI models at the edge of EHR systems.
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
Up to 4x
3 mo ObvioHealth average vs 12 mo benchmark for site-based trials
average retention vs. 70% benchmark for traditional trials
average per study (digital questionnaires, daily ediary, etc.).